Loading Vaishali Pharma…
| ₹ Cr | Mar 2025 |
|---|---|
| Revenue | 31 |
| Operating profit | 0 |
| Operating margin | 0.4% |
| Net profit | -4 |
| Net margin | -13.8% |
| EPS (₹) | — |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 105 | 98 | 82 | 64 | — |
| Operating profit | 6 | 6 | 6 | 9 | — |
| Operating margin | 5.4% | 6.0% | 7.8% | 14.1% | — |
| Net profit | 4 | 1 | 1 | 7 | — |
| Net margin | 3.8% | 0.8% | 0.9% | 10.3% | — |
| EPS (₹) | — | — | 0.07 | 0.59 | 0.38 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 123 | 110 | 80 | 79 |
| Total liabilities | 54 | 45 | 37 | 38 |
| Shareholders’ equity | 69 | 65 | 43 | 41 |
| Total debt | 19 | 12 | 13 | 15 |
| Cash & equivalents | 1 | 2 | 1 | 1 |
| Debt / equity | 0.27 | 0.19 | 0.31 | 0.36 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 0 | -18 | 1 | 1 |
| Capital expenditure | -0 | -0 | -0 | -0 |
| Free cash flow | -0 | -18 | 1 | 1 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 5.8% | 1.3% | 1.7% | 16.3% |
| Return on assets | 3.3% | 0.7% | 0.9% | 8.4% |
| Net margin | 3.8% | 0.8% | 0.9% | 10.3% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for VAISHALI. Finnhub coverage is limited for some India-listed stocks.